ICA Gruppen AB: Swedish Medical Products Agency Approves ICA Gruppen’s Acquisition of Apotek Hjärtat

Regulatory News:

ICA Gruppen’s acquisition of Apotek Hjärtat is subject to approval from the Swedish Medical Products Agency and the Swedish Competition Authority. The first of these two approvals has now been obtained.

The Swedish Medical Products Agency has decided that the notification of significant change, which was submitted to the Agency by reason of ICA Gruppen’s acquisition of Apotek Hjärtat, does not at present require any additional action from the Medical Products Agency. This means that the Medical Products Agency approves ICA Gruppen’s acquisition of Apotek Hjärtat.

The acquisition is also conditional on approval from the Swedish Competition Authority which is expected in April 2015 at the latest.

For further information, please contact

ICA Gruppen press office, telephone: 46 10 422 52 52

Investor Relations, Frans Benson, telephone: +46 8 561 500 20

ICA Gruppen AB discloses the information provided herein pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 07.45 CET on Friday, December 5th 2014.

ICA Gruppen AB (publ) is one of the Nordic region’s leading retail companies, with around 2,300 of its own and retailer-owned stores in Sweden, Norway, Estonia, Latvia and Lithuania. The Group includes the retail companies ICA Sweden, ICA Norway and Rimi Baltic, ICA Real Estate, which owns and manages properties and ICA Bank, which offers financial services to Swedish customers. The Group also includes the wholly owned portfolio company inkClub and partly owned portfolio companies Cervera and Hemtex. For more information see icagruppen.se (http://www.icagruppen.se)

This information was brought to you by Cision http://news.cision.com